Zydus gets DCGI approval for Saroglitazar Mg to treat non-alcoholic fatty liver disease
Saroglitazar Mg is already approved for the treatment of type-2 diabetes and NASH
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Non-Alcoholic Fatty Liver Disease
Zydus announces world’s first drug for the treatment of Non-Cirrhotic NASH
Saroglitazar, approved by DCGI becomes the first ever drug anywhere in the world for treatment of Non-Cirrhotic Non-Alcoholic…